1
To 10.65 at week 8 and maintained through the rest of the year, while for those on venlafaxine XR the HAM-A score reduced just to 12.80. Moreover, pregabalin also allowed patients to spend more time in a better health state: during one year, the number of weeks with no or minimal GAD was estimated to be 12.9 for pregabalin and 3.8 for venlafaxine XR. Concerning the primary measure of this analysis
1
To 10.65 at week 8 and maintained through the rest of the year, while for those on venlafaxine XR the HAM-A score reduced just to 12.80. Moreover, pregabalin also allowed patients to spend more time in a better health state: during one year, the number of weeks with no or minimal GAD was estimated to be 12.9 for pregabalin and 3.8 for venlafaxine XR. Concerning the primary measure of this analysis
1
To 10.65 at week 8 and maintained through the rest of the year, while for those on venlafaxine XR the HAM-A score reduced just to 12.80. Moreover, pregabalin also allowed patients to spend more time in a better health state: during one year, the number of weeks with no or minimal GAD was estimated to be 12.9 for pregabalin and 3.8 for venlafaxine XR. Concerning the primary measure of this analysis
1
To 10.65 at week 8 and maintained through the rest of the year, while for those on venlafaxine XR the HAM-A score reduced just to 12.80. Moreover, pregabalin also allowed patients to spend more time in a better health state: during one year, the number of weeks with no or minimal GAD was estimated to be 12.9 for pregabalin and 3.8 for venlafaxine XR. Concerning the primary measure of this analysis
1
To 10.65 at week 8 and maintained through the rest of the year, while for those on venlafaxine XR the HAM-A score reduced just to 12.80. Moreover, pregabalin also allowed patients to spend more time in a better health state: during one year, the number of weeks with no or minimal GAD was estimated to be 12.9 for pregabalin and 3.8 for venlafaxine XR. Concerning the primary measure of this analysis
1
To 10.65 at week 8 and maintained through the rest of the year, while for those on venlafaxine XR the HAM-A score reduced just to 12.80. Moreover, pregabalin also allowed patients to spend more time in a better health state: during one year, the number of weeks with no or minimal GAD was estimated to be 12.9 for pregabalin and 3.8 for venlafaxine XR. Concerning the primary measure of this analysis
1
Iapine 100 mg qd 10 100 mg qd 20 5 10 0.3 0.3 0 0 0.4 0.4 0 0 0.6 0.6 0.05 0 0.8 0.8 0.05 0.004 0.6 0.08 0.15 0 0.05 0.8 0.1 0.2 0 0.1 1.2 0.2 0.3 0.1 0.15 1.6 0.4 0.4 0.1 0.25 10 - 15 16 - 24Source: Expert panel. Blood analyses include glucose, gamma glutamyl transferase, creatinine, haemogram, sedimentation velocity, aspartate and alanine aminotransferase, urea and urinalysis.Silva Miguel et
1
Ations, according to the weights derived from the most recent National Inquiry of Health, whose data is from 2005/06 [23]. Thus, the weekly costs per patient used in the model were 12 for none or minimal, 16 for mild, 27 for moderate, and 40 for severe GAD. It should be noted that these values are an average of both alternatives and are therefore conservative, as the panel indicated that those pat